Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 1/20 | 0.42 |
| ▸ | SERPINE1 | P05121 | 17/20 | 0.41 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.37 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17878859 | 1.00 | P2RX4 (0.42) | P2RX4SERPINE1SMYD3LDHA | |
| SCHEMBL17740920 | 0.88 | SMYD3 (0.42) | SMYD3LDHA | |
| SCHEMBL17876842 | 0.86 | P2RX4 (0.44) | P2RX4SERPINE1LDHA | |
| SCHEMBL31670269 | 0.84 | ALDH1A1 (0.43) | P2RX4SERPINE1 | |
| SCHEMBL626788 | 0.84 | ALDH1A1 (0.43) | P2RX4SERPINE1 | |
| SCHEMBL19901701 | 0.84 | ALDH1A1 (0.43) | P2RX4SERPINE1 | |
| SCHEMBL17740896 | 0.84 | SMYD3 (0.42) | SMYD3LDHA | |
| SCHEMBL17740898 | 0.84 | SMYD3 (0.42) | SMYD3LDHA | |
| SCHEMBL17740897 | 0.84 | SMYD3 (0.42) | SMYD3LDHA | |
| SCHEMBL17740900 | 0.83 | SMYD3 (0.42) | SMYD3LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065302-A1 | SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF | FIRMENICH INCORPORATED | 2024-02-29 | — | — | US | disclosed |
| US-11339128-B2 | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers | FIRMENICH INCORPORATED (US) | 2022-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11339128-B2 | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers | TAS2R5, TAS2R4, TAS2R30 | P2RX4 592/4885SERPINE1 2046/4885SMYD3 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.